Revolution Medicines, Inc. (RVMD)

Last Closing Price: 37.01 (2025-08-22)

Earnings per Share (EPS) (Diluted) (Quarterly)

Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.

Revolution Medicines, Inc. (RVMD) had Earnings per Share (EPS) (Diluted) of $-1.31 for the most recently reported fiscal quarter, ending 2025-06-30.

Figures for fiscal quarter ending 2025-06-30
Income Statement Financials
--
$-247.79M
--
--
$264.71M
$-264.71M
$16.93M
$-247.79M
$-247.79M
$-247.79M
$-247.79M
$-247.79M
$-247.79M
$-264.71M
$-268.65M
188.58M
188.58M
$-1.31
Earnings per Share (EPS) (Diluted)
$-1.31
Balance Sheet Financials
$2.18B
$33.05M
$253.13M
$2.43B
$184.53M
$245.08M
$379.67M
$564.20M
$1.87B
$1.79B
$1.87B
186.90M
Cash Flow Statement Financials
$-416.19M
$18.33M
$257.46M
$546.76M
$406.35M
$-140.41M
$53.91M
--
--
Fundamental Metrics & Ratios
11.79
--
--
0.12
0.13
--
--
--
--
--
--
$-426.91M
--
--
--
--
--
--
--
-13.28%
-13.81%
-10.20%
-11.74%
$9.98
$-2.26
$-2.21